Gilead Sciences to Present at the Sanford C. Bernstein 26th Annual Strategic Decisions Conference on Thursday, June 3
May 27 2010 - 4:30PM
Business Wire
Gilead Sciences, Inc. (Nasdaq:GILD) today announced that its
corporate presentation will be webcast from the Sanford C.
Bernstein 26th Annual Strategic Decisions Conference in New
York.
John C. Martin, PhD, Gilead’s Chairman and Chief Executive
Officer, will provide an overview of the company on Thursday, June
3 at 2:00 p.m. Eastern Daylight Time.
To access the live webcast via the internet log on to
www.gilead.com. Please connect to the company’s website at least 15
minutes prior to the live presentation to ensure adequate time for
any software download that may be necessary to listen to the
webcast.
About Gilead
Gilead Sciences is a biopharmaceutical company that discovers,
develops and commercializes innovative therapeutics in areas of
unmet medical need. The company's mission is to advance the care of
patients suffering from life-threatening diseases worldwide.
Headquartered in Foster City, California, Gilead has operations in
North America, Europe and Australia.
For more information on Gilead
Sciences, please visit www.gilead.com or call the Gilead Public
Affairs Department at 1-800-GILEAD-5 (1-800-445-3235).
Gilead Sciences (NASDAQ:GILD)
Historical Stock Chart
From May 2024 to Jun 2024
Gilead Sciences (NASDAQ:GILD)
Historical Stock Chart
From Jun 2023 to Jun 2024